ERBB2 and breast carcinoma: Additionally, a systematic review that combines these findings with all available published results on the association of genome-wide genetic and epigenetic alterations in breast cancer tissue or blood with response to anti-HER2 treatment in HER2-positive breast cancer patients is also reported.